Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-25-109813
Filing Date
2025-11-13
Accepted
2025-11-13 13:03:05
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0265549-424b5_hoth.htm 424B5 11538
2 GRAPHIC image_001.jpg GRAPHIC 8994
  Complete submission text file 0001213900-25-109813.txt   25125
Mailing Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR SUITE 5066 NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 5TH FLOOR SUITE 5066 NEW YORK NY 10036 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-272620 | Film No.: 251476966
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)